Similar articles

• [Study tests Varicella-Zoster vaccine for over 60-years-old persons. Protection from Herpes zoster and postherpetic neuralgia].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2006;Spec no.1:14-5. MMW Fortschr Med. 2006. PMID: 16872127 German. No abstract available.
• [Two U.S. experts discuss the consequences of the "Shingles Prevention Study". Is senior vaccination worthwhile in the practice?].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2006;Spec no.1:16. MMW Fortschr Med. 2006. PMID: 16872128 German. No abstract available.
• Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.

  Betts RF. Betts RF. J Am Acad Dermatol. 2007 Dec;57(6 Suppl):S143-7. doi: 10.1016/j.jaad.2007.09.017. J Am Acad Dermatol. 2007. PMID: 18021866 Clinical Trial.
• A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.

  Holcomb K, Weinberg JM. Holcomb K, et al. J Drugs Dermatol. 2006 Oct;5(9):863-6. J Drugs Dermatol. 2006. PMID: 17039651 Review.
• Vaccination to prevent herpes zoster and postherpetic neuralgia.

  Oxman MN. Oxman MN. Hum Vaccin. 2007 Mar-Apr;3(2):64-8. doi: 10.4161/hv.3.2.3746. Epub 2007 Mar 23. Hum Vaccin. 2007. PMID: 17299270 Review. No abstract available.